Paper Details

  1. Home
  2. Paper Details

Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.

Author: , BellantonioPaolo, Brescia-MorraVincenzo, CentonzeDiego, ClericoMarinella, CottoneSalvatore, De LucaGiovanna, FlorioCiro, LugaresiAlessandra, MarcellusiAndrea, PaolilloAndrea, UccelliAntonio, di IoiaMaria

Clinical Trial, Phase IVPost-marketing surveillance. Monitors long-term safety/efficacy after approval.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study assessed short-term adherence to, and tolerability of, interferon (IFN) β-1a administered via electronic autoinjection device in patients with relapsing-remitting multiple sclerosis (RRMS). The results suggest that electronic autoinjection devices may improve adherence to self-injected treatments for multiple sclerosis.
Paper Details　
Original Abstract of the Article :
Achieving good adherence to self-injected treatments for multiple sclerosis can be difficult. Injection devices may help to overcome some of the injection-related barriers to adherence that can be experienced by patients. We sought to assess short-term adherence to, and tolerability of, interferon (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368780/

データ提供：米国国立医学図書館（NLM）

Self-Administered Interferon β-1a: A Step Towards Better Multiple Sclerosis Management

For those living with multiple sclerosis (MS), adherence to self-administered treatments can be a significant challenge. This study examines the short-term adherence to and tolerability of interferon (IFN) β-1a delivered via an electronic autoinjection device in patients with relapsing-remitting MS (RRMS). The study aims to assess the impact of this device on injection-related barriers to adherence, which can be a major hurdle for patients.

Empowering Patients: The Role of Technology in MS Management

The use of an electronic autoinjection device for IFN β-1a administration offers potential benefits for patients with MS. By simplifying the injection process and addressing some of the inherent barriers to adherence, this technology could empower patients to effectively manage their condition. Further research is needed to evaluate the long-term impact of this device on adherence and disease progression.

Living with MS: A Journey of Adaptation and Support

Managing MS requires a multifaceted approach, combining medication, lifestyle modifications, and emotional support. The development of user-friendly devices like the electronic autoinjection system represents a significant advancement in MS management. It encourages patients to actively participate in their treatment, fostering a sense of control and empowering them to navigate the complexities of living with MS.

Dr.Camel's Conclusion

Just as a camel adapts to the harsh desert environment, those with MS must adapt to the challenges of their condition. This study highlights the potential of technology to make life easier for patients, simplifying treatment and promoting adherence. It serves as a reminder that ongoing research and innovation are crucial for improving the lives of those living with MS, offering them more tools to navigate their journey with greater ease and confidence.

Date :
  1. Date Completed 2012-08-31
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

22390218

DOI: Digital Object Identifier

PMC3368780

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.